CCL3-dependent MMP9 upregulation in ESCC cells may be not universal, and may occur via other signaling pathways, such as p38 MAPK, AMPK, or NF-κB, which were also reported to be activated downstream of CCL3–CCR5 axis [21, 49]. The gene discussed is CCR5; the disease is esophageal squamous cell carcinoma.